December 17, 2019

Letter to Congress on "Cures 2.0" updates to 21st Century Cures Act

In response to Rep. Diana DeGette's (D-CO) and Rep. Fred Upton's (R-MI) request for stakeholder input on how to modernize how new cures and medical products are covered by health insurance, including Medicare and Medicaid, the Alliance submitted a letter offering our recommendations on how reform of Medicare coding, coverage and payment could better support patients’ access to innovative therapies. The letter focused on three main topics: (1) contractor coverage issues that need revising from 21st Century Cures, (2) transparency issues in coverage and coding processes, and (3) the importance of real-world evidence and the need for reporting of more wound-relevant quality measures.
Read Alliance letter

July 21, 2019

Comments to AHRQ RFI on "The Impact & Use of Evidence-Based Practice Center Evidence Reviews"

The Alliance responded to AHRQ's request for information on "The Impact and Use of Evidence-Based Practice Center (EPC) Evidence Reviews." Our comments noted that AHRQ reviews in the wound care space tend to be "myopic", with significant errors and with key questions that are too narrowly focused to impact coverage.  We provided suggestions to AHRQ on how the evidence reviews can be more useful and impactful to the wound care space, including: Require key investigators to actually practice in the area of the report; Conduct assessments/reviews  independent of coverage or payment; and, Utilize real-world data/evidence and/or registry data when reviewing chronic wound care issues.
Read Alliance Comment
logo
Follow us on:
linkedin